Vimarsana
Biggest News Aggregation in the World

Lee Cranmer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lee Cranmer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lee Cranmer Today - Breaking & Trending Today

Aadi Bioscience Announces Presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting - Vimarsana News

Aadi Bioscience Announces Presentations at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision...

Aadi Bioscience Announces Multiple Presentations on nab-Sirolimus at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting - Vimarsana News

Aadi Bioscience Announces Multiple Presentations on nab-Sirolimus at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

/PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision...

Avacta opens two US sites and doses first patient in sarcoma drug trial - Vimarsana News

Avacta opens two US sites and doses first patient in sarcoma drug trial

TWO US clinical investigator sites have been opened for a phase 1 clinical trial for patients with soft tissue sarcoma and the first patient has been dosed.

Salarius Pharmaceuticals Adds Seattle Cancer Care Alliance and Oregon Health & Sciences as Clinical Sites for its Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas - Vimarsana News

Salarius Pharmaceuticals Adds Seattle Cancer Care Alliance and Oregon Health & Sciences as Clinical Sites for its Ongoing Trial of Seclidemstat as a Treatment for Ewing Sarcoma and FET-Rearranged Sarcomas

HOUSTON, Aug. 04, 2022 -- Salarius Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing therapies for patients with cancer in need of new treatment options, announces the... | August 4, 2022